Stock Market Reviews

TEVA (Teva Pharmaceutical Industries Limited) News

Get the latest news, insights, and market updates on TEVA (Teva Pharmaceutical Industries Limited). Explore the news page 8 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Teva Hits Highest Since 2018 as 3Q Revenue Beats Estimates
  Teva Pharmaceutical CEO Richard Francis speaks about 3Q earnings on Bloomberg BusinessWeek with Bloomberg's Katie Greifeld and Emily Graffeo.
  Nov 5, 2025 - $TEVA
• Sector Update: Health Care Stocks Higher in Afternoon Trading
  Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index up 0.5% and the Health
  Nov 5, 2025 - $TEVA
• Top Midday Stories: McDonald's Shares Rise After Q3 Same-Store Sales Growth; AMD Q3 Adjusted EPS, Revenue Beat Estimates
  All three major US stock indexes were up in late-morning trading Wednesday, as some big artificial-i
  Nov 5, 2025 - $TEVA
• Sector Update: Health Care Stocks Advance Late Afternoon
  Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index gaining 0.4% and th
  Nov 5, 2025 - $TEVA
• Apple's reported Google deal, Teva & Axon post-earnings moves
  Market Domination host Josh Lipton examines some of Wednesday's trending tickers. Apple (AAPL) is reportedly nearing a deal with Alphabet (GOOG, GOOGL) to overhaul Siri, according to Bloomberg. Teva (TEVA) stock rose after the company reported earnings, while Axon (AXON) stock fell after the company's quarterly results missed estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination.
  Nov 5, 2025 - $TEVA
• Teva Pharmaceutical Industries Ltd (TEVA) Q3 2025 Earnings Call Highlights: Strong Growth ...
  Teva Pharmaceutical Industries Ltd (TEVA) reports its 11th consecutive quarter of growth, driven by innovative products, despite facing challenges in the generics market and cash flow.
  Nov 5, 2025 - $TEVA
• Why Teva Pharmaceutical Stock Rocked the Market Today
  The company delivered a convincing pair of beats in its third-quarter earnings report.
  Nov 5, 2025 - $TEVA
• Teva Rockets, Reaffirming Its $2.5 Billion View For Austedo After IRA Negotiations
  Teva stock rocketed into a profit-taking zone Wednesday after the company put up a big sales beat for its drug Austedo in the U.S.
  Nov 5, 2025 - $TEVA